Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Piper crocatum extract is a botanical substance derived from the red betel leaf, a plant native to Indonesia traditionally utilized in herbal medicine. The extract is characterized by a high concentration of bioactive compounds, including flavonoids, polyphenols, alkaloids, tannins, and steroids, which impart antioxidant, anti-inflammatory, and hypoglycemic properties. It is currently being investigated as a functional food ingredient, often delivered in the form of cookies or gels, for the management and prevention of chronic diabetic complications such as diabetic neuropathy, nephropathy, and dyslipidemia. Its therapeutic mechanism involves the modulation of inflammatory biomarkers like Matrix metalloproteinase-9 (MMP-9) and Neutrophil gelatinase-associated lipocalin (NGAL), as well as the regulation of cytokine expression and oxidative stress pathways. Clinical development is primarily academic-led, focusing on its potential as an adjunct therapy to stabilize blood glucose and protect against organ-specific damage in metabolic diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on piper crocatum extract.